Notify me when John Lipman files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| USCTF | Roth CH Acquisition Co. | Class A Ordinary Shares, $0.0001 par value per share | 27% | $16,351,131 | 12,111,949 | John Lipman | 24 Jan 2025 | ||
| NDRA | ENDRA Life Sciences Inc. | Common Stock, par value $0.0001 | 10% | 115,477 | John Carter Lipman | 23 Oct 2025 | |||
| NEHC | NEW ERA HELIUM INC. | COMMON STOCK, PAR VALUE $0.0001 PER SHARE | 6.4% | $760,099 | 844,554 | John Lipman | 09 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|